Patients with Crohn’s disease have a new treatment option, following U.S. Food and Drug Administration approval of a pill called Rinvoq (upadacitinib).
This article was originally published on MedicalXpress.com
FDA approves first pill to treat moderate-to-severe Crohn's disease
You may also be interested in:
The Latest
Toxic, long-lasting contaminants detected in people living in northern Canada
Researchers have recently found that several long-lasting human-made contaminants have been building up in Arctic lakes, polar bears and ringed seals and other wildlife. These contaminants belong to a family of chemicals called polyfluoroalkyl and perfluoroalkyl substances (PFAS), […]
The Latest
Microneedling Services in Edmonton: Benefits, Treatment Cost, and How It Works
Microneedling is a revolutionary skincare treatment that has gained popularity in recent years due to its numerous benefits, including reducing the appearance of scars, wrinkles, and acne, and promoting collagen production. Edmonton, the bustling capital […]
The Latest
Eminence Organic Skin Care – The Best in Natural and Organic Skincare
You deserve the best of the best when it comes to taking care of your skin, and that’s exactly what you’ll get with Eminence Organic Skin Care. With over 60 years of experience in professional organic […]
Read More:
-
According to the U.S. Surgeon General, women should not drink alcoholic beverages during pregnancy because of the risk of birth defects in their unborn child. [...]
-
New technologies that can capture subtle changes in a patient’s voice may help physicians diagnose cognitive impairment and Alzheimer’s disease before symptoms begin to show, [...]
-
The COVID-19 pandemic led to increased weekday screentime for school-aged children says a new study involving the University of Ottawa published in JAMA Pediatrics.This article [...]
